Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.00
$0.01
$0.00
$0.22
$40K-0.5744,947 shs1 shs
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
$7.20
-9.7%
$7.24
$5.11
$3,756.00
$3.46M-0.24475,941 shs344,716 shs
Vapotherm, Inc. stock logo
VAPO
Vapotherm
$2.17
$2.16
$0.70
$3.44
$13.58M-1.11N/A51,531 shs
Venus Concept Inc. stock logo
VERO
Venus Concept
$2.49
-0.4%
$2.45
$2.10
$14.50
$3.54M0.07694,243 shs25,650 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00%-36.36%-51.72%-96.89%-95.48%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
+36.71%+41.06%+26.11%-5.19%-99.50%
Vapotherm, Inc. stock logo
VAPO
Vapotherm
0.00%0.00%0.00%0.00%+0.93%
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00%-4.21%+12.61%-3.10%-61.48%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.3401 of 5 stars
0.02.00.00.02.70.80.0
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/AN/AN/AN/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
0.9945 of 5 stars
0.01.00.00.02.83.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00
N/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.00
N/AN/AN/A
Vapotherm, Inc. stock logo
VAPO
Vapotherm
0.00
N/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$7.16M0.01N/AN/A($0.03) per share-0.05
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/A($983.43) per shareN/A
Vapotherm, Inc. stock logo
VAPO
Vapotherm
$68.67M0.20N/AN/A($9.01) per share-0.24
Venus Concept Inc. stock logo
VERO
Venus Concept
$64.83M0.05N/AN/A$4.30 per share0.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-$81.66MN/A0.00N/A-272.74%-311.64%-11.57%N/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-$22.60M-$56.60N/AN/AN/AN/A-544.87%N/A
Vapotherm, Inc. stock logo
VAPO
Vapotherm
-$58.19M-$8.51N/AN/A-76.74%N/A-68.08%N/A
Venus Concept Inc. stock logo
VERO
Venus Concept
-$47M-$76.30N/AN/A-81.26%-752.29%-54.52%8/14/2025 (Estimated)

Latest VAPO, AFIB, VERO, and GCTK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Venus Concept Inc. stock logo
VERO
Venus Concept
-$14.08-$17.44-$3.36-$17.44$14.59 million$13.64 million
5/14/2025Q1 2025
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/A-$20.40N/A-$0.67N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/AN/A
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/A
1.85
1.57
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.03
4.85
4.85
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/A
0.25
0.09
Venus Concept Inc. stock logo
VERO
Venus Concept
7.91
1.28
0.79

Institutional Ownership

CompanyInstitutional Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
56.91%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
10.92%
Vapotherm, Inc. stock logo
VAPO
Vapotherm
43.08%
Venus Concept Inc. stock logo
VERO
Venus Concept
87.41%

Insider Ownership

CompanyInsider Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
5.21%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
12.91%
Vapotherm, Inc. stock logo
VAPO
Vapotherm
15.80%
Venus Concept Inc. stock logo
VERO
Venus Concept
28.04%
CompanyEmployeesShares OutstandingFree FloatOptionable
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
34029.78 million28.23 millionOptionable
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
5480,000416,000Not Optionable
Vapotherm, Inc. stock logo
VAPO
Vapotherm
2906.26 million5.27 millionNo Data
Venus Concept Inc. stock logo
VERO
Venus Concept
4101.42 million1.03 millionNot Optionable

Recent News About These Companies

VERO - Venus Concept Inc Financials - Morningstar
Venus Concept Inc News (VERO) - Investing.com
Venus Concept Shares Soar on Sale of Hair Business

New MarketBeat Followers Over Time

Media Sentiment Over Time

Acutus Medical stock logo

Acutus Medical NASDAQ:AFIB

$0.0014 0.00 (0.00%)
As of 07/21/2025

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

GlucoTrack stock logo

GlucoTrack NASDAQ:GCTK

$7.20 -0.77 (-9.66%)
Closing price 04:00 PM Eastern
Extended Trading
$7.05 -0.15 (-2.08%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Vapotherm stock logo

Vapotherm NYSE:VAPO

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Venus Concept stock logo

Venus Concept NASDAQ:VERO

$2.49 -0.01 (-0.40%)
Closing price 04:00 PM Eastern
Extended Trading
$2.49 0.00 (0.00%)
As of 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.